Melanoma and immunotherapy bridge 2015Naples, Italy. 1–5 December 2015

被引：6

作者：

Vashisht G. Y. Nanda

Weiyi Peng

Patrick Hwu

Michael A. Davies

Gennaro Ciliberto

Luigi Fattore

Debora Malpicci

Luigi Aurisicchio

Paolo Antonio Ascierto

Carlo M. Croce

Rita Mancini

Stefani Spranger

Thomas F. Gajewski

Yangyang Wang

Soldano Ferrone

Claire Vanpouille-Box

Erik Wennerberg

Karsten A. Pilones

Silvia C. Formenti

Sandra Demaria

Haidong Tang

Yang Wang

Yang-Xin Fu

Reinhard Dummer

Igor Puzanov

Ahmad Tarhini

Joe-Marc Chauvin

Ornella Pagliano

Julien Fourcade

Zhaojun Sun

Hong Wang

Cindy Sanders

John M. Kirkwood

Tseng-hui Timothy Chen

Mark Maurer

Alan J. Korman

Hassane M. Zarour

David F. Stroncek

Veronica Huber

Licia Rivoltini

Magdalena Thurin

Tilman Rau

Alessandro Lugli

Franck Pagès

Jorge Camarero

Arantxa Sancho

Claudio Jommi

Yago Pico de Coaña

Maria Wolodarski

Yuya Yoshimoto

机构：

[1] University of Texas MD Anderson Cancer Center,Department of Melanoma Medical Oncology

[2] Istituto Nazionale per lo Studio e la Cura dei Tumori “Fondazione G. Pascale”,Dipartimento di Medicina Sperimentale e Clinica

[3] Università degli Studi di Catanzaro “Magna Graecia”,Department of Molecular Virology, Immunology and Medical Genetics

[4] Takis s.r.l.,Dipartimento di Chirurgia “P. Valdoni”

[5] The Ohio State University Comprehensive Cancer Center,Dipartimento di Medicina Clinica e Molecolare

[6] Sapienza Università di Roma,Department of Pathology

[7] Sapienza Università di Roma,Department of Medicine

[8] University of Chicago,Department of Surgery

[9] University of Chicago,Department of Pathology

[10] Massachusetts General Hospital,Department of Radiation Oncology

[11] Harvard Medical School,Department of Radiation Oncology

[12] NYU School of Medicine,Department of Pathology

[13] NYU School of Medicine,Department of Dermatology

[14] Weill Cornell Medical College,Vanderbilt

[15] University of Texas Southwestern,Ingram Cancer Center

[16] University of Zurich Hospital,Melanoma and Skin Cancer Program

[17] Vanderbilt University,Department of Medicine and Division of Hematology/Oncology

[18] Memorial Sloan Kettering Cancer Center,Department of Immunology

[19] University of Pittsburgh Cancer Institute,Department of Biostatistics, School of Medicine

[20] University of Pittsburgh,Biologics Discovery California

[21] University of Pittsburgh,Cell Processing Section, Department of Transfusion Medicine, Clinical Center

[22] School of Medicine,Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis

[23] University of Pittsburgh,Institute of Pathology

[24] Bristol-Myers Squibb,Laboratory of Immunology

[25] National Institutes of Health,INSERM team 15

[26] Fondazione IRCCS Istituto Nazionale dei Tumori,Department of Pharmaceutical Sciences

[27] NCI,Cergas (Centre for Research on Health and Social Care Management)

[28] NIH,Department of Oncology

[29] University of Bern,Pathology, Cancer Center Karolinska

[30] Hopital Européen Georges Pompidou,Division of Translational Medicine

[31] Cordeliers Research Center,Division of Molecular Oncology of Gastrointestinal Tumors

[32] Oncology Area,Pathology Unit

[33] Spanish Medicines Agency and Medical Devices (AEMPS),Faculty of Pharmacy and Medicine, Department of Medicine

[34] Research Institute Hospital Puerta de Hierro Majadahonda,Molecular Immunology and Immuneregulation

[35] Università del Piemonte Orientale,Department of Pharmacy

[36] Università Bocconi,Unit of Medical Oncology and Innovative Therapy

[37] Karolinska Institutet,Melanoma and Immunotherapies Service

[38] Sidra Medical and Research Center,Dermatology Unit

[39] German Cancer Research Center,Department of Medical Oncology and Hematology

[40] Istituto Nazionale per lo Studio e la Cura dei Tumori Fondazione “G. Pascale”,Division of Immunology

[41] University of Salerno,Department of Medicine

[42] Istituto Nazionale per lo Studio e la Cura dei Tumori “Fondazione G. Pascale”,Department of Medicine

[43] University of Naples Federico II,Melanoma Center

[44] Istituto Nazionale per lo Studio e la Cura Tumori Fondazione “G. Pascale”,Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy

[45] Memorial Sloan Kettering Cancer Center,Divisione chirurgia dermatoncologica

[46] Institut Gustave Roussy,Institute of Cancer Sciences

[47] The Royal Marsden Hospital,Dermatologische Klinik

[48] The Netherlands Cancer Institute,Division of Hematology and Oncology

[49] Jonsson Comprehensive Cancer Center at University of California Los Angeles,Department of Medicine

[50] Princess Margaret Hospital and University Health Network,Department of Biostatistics

来源：

Journal of Translational Medicine | / 14卷 / Suppl 1期

关键词：

Melanoma; Overall Survival; Melanoma Cell; Melanoma Patient; Melanoma Cell Line;

D O I：

10.1186/s12967-016-0791-2

中图分类号：

学科分类号：

摘要：

MELANOMA BRIDGE 2015

引用